TY - JOUR
T1 - Recent applications of phase-change materials in tumor therapy and theranostics
AU - He, Mengying
AU - Wang, Yuhan
AU - Li, Dazhao
AU - Zhang, Mengyao
AU - Wang, Tong
AU - Zhi, Feng
AU - Ji, Xingyue
AU - Ding, Dawei
N1 - Publisher Copyright:
© 2023
PY - 2023/4
Y1 - 2023/4
N2 - Phase-change materials (PCMs) are a type of special material which can store and release a large amount of thermal energy without any significant temperature change. They are emerging in recent years as a promising functional material in tumor therapy and theranostics due to their accurate responses to the temperature variations, biocompatibility and low toxicity. In this review, we will introduce the main types of PCMs and their desirable physiochemical properties for biomedical applications, and highlight the recent progress of PCM's applications in the modulated release of antitumor drugs, with special attentions paid to various ways to initiate temperature-dependent phase change, the concomitant thermal therapy and its combination with or activation of other therapies, particularly unconventional therapies. We will also summarize PCM's recent applications in tumor theranostics, where both drugs and imaging probes are delivered by PCMs for controlled drug release and imaging-guided therapy. Finally, the future perspectives and potential limitations of harnessing PCMs in tumor therapy will be discussed.
AB - Phase-change materials (PCMs) are a type of special material which can store and release a large amount of thermal energy without any significant temperature change. They are emerging in recent years as a promising functional material in tumor therapy and theranostics due to their accurate responses to the temperature variations, biocompatibility and low toxicity. In this review, we will introduce the main types of PCMs and their desirable physiochemical properties for biomedical applications, and highlight the recent progress of PCM's applications in the modulated release of antitumor drugs, with special attentions paid to various ways to initiate temperature-dependent phase change, the concomitant thermal therapy and its combination with or activation of other therapies, particularly unconventional therapies. We will also summarize PCM's recent applications in tumor theranostics, where both drugs and imaging probes are delivered by PCMs for controlled drug release and imaging-guided therapy. Finally, the future perspectives and potential limitations of harnessing PCMs in tumor therapy will be discussed.
KW - Controlled release
KW - Phase-change materials
KW - Temperature responsiveness
KW - Tumor theranostics
KW - Tumor therapy
UR - http://www.scopus.com/inward/record.url?scp=85147332722&partnerID=8YFLogxK
U2 - 10.1016/j.bioadv.2023.213309
DO - 10.1016/j.bioadv.2023.213309
M3 - Review article
AN - SCOPUS:85147332722
SN - 2772-9508
VL - 147
JO - Biomaterials Advances
JF - Biomaterials Advances
M1 - 213309
ER -